Patients' preferences for once-daily oral versus once-weekly injectable diabetes medications: The REVISE study.

Kristina BoyeMelissa M RossReema ModyManige KonigHeather L Gelhorn

Published in: Diabetes, obesity & metabolism (2020)

Several treatment-related characteristics, including route, frequency and complexity of the treatment, play a role in patients' preferences for T2DM treatments and should be considered during treatment selection.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
cardiovascular disease
prognostic factors
physical activity
metabolic syndrome
patient reported
replacement therapy